Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$656,713,046
+$348,921,977 QoQ
Shares Held
18,556,458
+67.0% QoQ
Ownership
2.57%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#7
of 489 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$12,219,706
PutShares
1,058,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,039,430,805 across 359 Biotechnology names. ROIV ranks #3 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
This page
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ROIV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $656,713,046 | 18,556,458 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $307,791,069 | 11,111,591 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $238,324,219 | 10,982,683 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $35,722,927 | 2,361,066 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $33,104,124 | 2,937,367 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,552,863 | 2,433,386 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $24,944,997 | 2,108,622 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $62,228,007 | 5,392,375 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $12,219,706 | 1,058,900 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $44,408,109 | 4,201,335 | Shares | Defined | 2024-08-13 | |
| 2024-06-30 | $1,063,342 | 100,600 | Call | Defined | 2024-08-13 | |
| 2024-03-31 | $15,798,573 | 1,498,916 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,639,056 | 413,095 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,828,066 | 242,129 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $999,411 | 99,148 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $13,100,909 | 1,775,191 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,165,522 | 521,342 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $639,492 | 198,600 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $819,209 | 201,280 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $99,743 | 20,191 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||